DAIC

MARCH 14, 2025

Some of the late-breaking topics that will be covered include transcatheter aortic valve replacement (TAVR), peripheral artery disease (PAD), and pulmonary embolism (PE): Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation (..)

TAVR 52

TAVR Aortic valve Peripheral Arterial Disease Embolism 52

American College of Cardiology

OCTOBER 28, 2024

The goal of the EARLY TAVR trial was to evaluate transcatheter aortic valve replacement (TAVR) compared with clinical surveillance among patients with asymptomatic severe aortic stenosis (stage C aortic stenosis).

TAVR 63

TAVR Stenosis Aortic Aortic valve 63

DAIC

JANUARY 29, 2024

Getty Images milla1cf Mon, 01/29/2024 - 14:24 January 29, 2024 — Despite national guidelines recommending surgical aortic valve replacement (SAVR) for patients under age 65 with severe aortic stenosis , many hospitals are still opting for a nonsurgical approach in patients under 60—possibly with poorer survival rates. for SAVR vs. 0.4%

Aortic valve 111

Aortic valve TAVR Aortic Outcomes 111

Frontiers in Cardiovascular Medicine

MARCH 9, 2025

Transcatheter aortic valve replacement (TAVR) has become a leading treatment for aortic stenosis, but managing thromboembolic and bleeding risks post-procedure remains challenging. This review examines current evidence on antithrombotic therapy after TAVR.

Aortic valve 52

Aortic valve Aortic TAVR Thrombosis 52

American College of Cardiology

APRIL 22, 2024

What is the 5-year incidence of valve reintervention after self-expanding CoreValve/Evolut transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR)?

TAVR 69

TAVR Aortic Aortic valve Stenosis 69

American College of Cardiology

MARCH 30, 2025

Patients with severe aortic stenosis who were treated with either TAVR or surgery had comparable rates of all-cause mortality or disabling stroke at five years, according to research presented during a Late-Breaking Clinical Trial session at ACC.25 25 in Chicago and simultaneously published in JACC.

TAVR 69

TAVR Stenosis Aortic Research 69

American College of Cardiology

MARCH 6, 2024

What are the hemodynamic and clinical outcomes after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) among patients with severe aortic stenosis (AS) and a small aortic annulus?

TAVR 60

TAVR Aortic Stenosis Aortic valve 60

HCPLive

OCTOBER 13, 2024

Linda Gillam, MD, MPH, discusses updates in the management of aortic stenosis, with a focus on use of TAVR.

TAVR 52

TAVR Stenosis Aortic 52

HCPLive

JANUARY 30, 2024

A recent statewide analysis in California found TAVR rates exceed SAVR for severe aortic stenosis, despite contradicting consensus guideline recommendations.

TAVR 72

TAVR Stenosis Aortic 72

Frontiers in Cardiovascular Medicine

MARCH 20, 2025

All patients were pre-TAVR assessed by transthoracic echocardiography and computed tomography of the aortic valve (AV) and relevant left cardiac and vascular anatomy. Nanjing) to evaluate its safety and efficacy.Methods130 high risk patients with symptomatic severe AS from 11 institutions were treated with the novel Xcor system.

Aortic valve 52

Aortic valve Aortic Bicuspid/Mitral Stenosis 52

Becker's Hospital Review - Cardiology

MAY 14, 2024

UPMC Harrisburg pioneers new transcatheter aortic valve replacement system, providing improved lifetime management for patients with aortic valve stenosis.

Aortic valve 92

Aortic valve TAVR Aortic Stenosis 92

Frontiers in Cardiovascular Medicine

FEBRUARY 6, 2025

IntroductionClinical evidence highlighting the efficacy and safety of transcatheter aortic valve replacement (TAVR) and the 2019 Food and Drug Administration (FDA) approval for TAVR in low-risk (younger) patients has created a demand for durable and long-lasting bioprosthetic heart valve (BHV) leaflet materials.

Heart Valves 52

Heart Valves Aortic TAVR Aortic valve 52

Heart BMJ

JANUARY 29, 2025

Background Subclinical leaflet thrombosis (SLT) is a common complication after transcatheter aortic valve replacement (TAVR). Methods This prospective cohort study consecutively enrolled patients with severe symptomatic aortic stenosis who underwent successful TAVR. Trial registration number ChiCTR2300072300.

Aortic valve 52

Aortic valve Thrombosis Aortic Technology 52

CardiacWire

JANUARY 31, 2024

Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aortic valve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. The post SAVR’s Value in the TAVR Era appeared first on Cardiac Wire.

TAVR 69

TAVR Aortic valve Bicuspid/Mitral Aortic 69

American College of Cardiology

JUNE 18, 2024

In this week's View, Dr. Eagle looks at secular trends of incidence and outcomes in severe aortic stenosis. He then examines titration of medications after acute heart failure.

Heart Failure 58

Heart Failure Stenosis Aortic TAVR 58

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

This concept should be applied when managing older patients with severe aortic stenosis. Although left ventricular wall hypertrophy is expected in patients with aortic stenosis, it should not be assumed that this is caused only by aortic stenosis.

Stenosis 69

Stenosis Aortic TAVR Aortic valve 69

Med Page Today

JUNE 10, 2024

(MedPage Today) -- NEW YORK CITY -- With valve-in-valve procedures becoming a key concern for patients with aortic stenosis, familiar transcatheter aortic valve replacement (TAVR) devices are being tweaked to facilitate future operations that.

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

Frontiers in Cardiovascular Medicine

AUGUST 7, 2024

Aortic Stenosis (AS) is a common condition with an estimated pooled prevalence of all AS in the elderly population at around 12.4%, with that of severe AS estimated to be around 3.4%. Therefore, alternative TAVR approaches have gained increasing utility in cases where transfemoral access is unfavorable.

Aortic valve 98

Aortic valve Aortic TAVR Peripheral Arterial Disease 98

American College of Cardiology

OCTOBER 28, 2024

Two separate late-breaking clinical trials – EARLY TAVR and EVOLVED – presented at TCT 2024 explore whether early aortic valve intervention improves outcomes in patients with asymptomatic aortic stenosis (AS).

TAVR 53

TAVR Aortic valve Aortic Stenosis 53

Heart BMJ

JULY 10, 2024

Valvular heart disease, including calcific or degenerative aortic stenosis (AS), is increasingly prevalent among the older adult population. Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR).

Aortic valve 98

Aortic valve Aortic Quality of Life TAVR 98

Journal of Cardiothoracic Surgery

JULY 29, 2024

Transcatheter aortic valve replacement (TAVR) has increased in utilization since its approval for management of aortic stenosis patients across all risk strata. We report a rare case of aortic valve leaflet av.

Aortic valve 52

Aortic valve TAVR Aortic Stenosis 52

Open Heart

FEBRUARY 27, 2024

Objectives The clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active cancer remain insufficiently explored. This study aimed to assess the midterm outcomes of TAVR in patients diagnosed with AS and active cancer. vs 74.7%, p=0.50).

Aortic valve 98

Aortic valve Cancer Aortic TAVR 98

JAMA Cardiology

OCTOBER 29, 2024

American College of Cardiology/American Heart Association guideline recommendations for transcatheter aortic valve replacement (TAVR) transitioned in 2020 from decision-making based on estimated risk of surgical valve replacement (SAVR) to one based on patient age and expected longevity.

TAVR 40

TAVR Aortic Stenosis Aortic valve 40

Medical Xpress - Cardiology

MAY 2, 2024

A nationwide observational analysis of patients with aortic stenosis (AS) and cardiogenic shock (CS) who underwent transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) determined that patients who underwent TAVR had lower in-hospital complications and resource utilization compared with SAVR.

Cardiogenic Shock 40

Cardiogenic Shock TAVR Stenosis Aortic valve 40

Society of Thoracic Surgeons - Congenital

JANUARY 25, 2025

Hunter Mehaffey, MD, a cardiothoracic surgeon from West Virginia University, will examine results comparing two treatment options Transcatheter vs. Surgical Aortic Valve Replacement in Medicare Beneficiaries with Aortic Stenosis and Significant Coronary Disease.

Medicare 52

Medicare Coronary Artery Disease Stenosis Aortic 52

American College of Cardiology

APRIL 16, 2025

TAVR was associated with similar and stable valve hemodynamics and improved hemodynamic burden on both left and right ventricular function at five years compared with SAVR in low-risk patients with severe aortic stenosis (AS), according to a new echocardiographic analysis from PARTNER 3 published April 16.

TAVR 40

TAVR Stenosis Aortic Article 40

DAIC

MARCH 12, 2024

A cost-effectiveness analysis demonstrates the positive economic value of transcatheter aortic valve replacement (TAVR) using Evolut TAVR compared to surgical aortic valve replacement (SAVR) for low-risk patients. The findings showed a strong economic benefit of Evolut TAVR for low-risk patients from a U.S.

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

Medical Xpress - Cardiology

OCTOBER 29, 2024

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate aortic stenosis (AS).

Aortic valve 45

Aortic valve Aortic Heart Failure Stenosis 45

NEJM Journal Watch - Cardiology

MARCH 18, 2025

A small randomized study failed to show a benefit of TAVR in this population.

TAVR 40

TAVR Heart Failure Stenosis Aortic 40

Medical Xpress - Cardiology

MAY 3, 2024

Additional analysis from the SMall Annuli Randomized To Evolut or SAPIEN (SMART) study demonstrated clinical non-inferiority of self-expanding valves (SEV) versus balloon-expandable valves (BEV) in aortic stenosis patients undergoing transcatheter aortic valve replacement (TAVR) and confirmed valve performance superiority over time based on hemodynamics. (..)

TAVR 40

TAVR Aortic valve Aortic Stenosis 40

American College of Cardiology

APRIL 4, 2024

The goal of the VIVA trial was to evaluate transcatheter aortic valve replacement (TAVR) compared with surgical aortic valve replacement (SAVR) among patients with severe aortic stenosis and a small aortic annulus.

Aortic valve 50

Aortic valve Aortic Stenosis TAVR 50

AMS Cardiology

APRIL 16, 2024

If you’ve been diagnosed with aortic stenosis, you might have come across the term TAVR. If you’re wondering “ What is TAVR ?” Understanding Aortic Stenosis The aortic valve regulates blood flow from your heart’s main pumping chamber to the rest of your body. Who Is a Candidate for TAVR?

Aortic valve 40

Aortic valve TAVR Aortic Open-Heart Surgery 40

Open Heart

OCTOBER 19, 2022

Objective A novel artificial intelligence-based phenotyping approach to stratify patients with severe aortic stenosis (AS) prior to transcatheter aortic valve replacement (TAVR) has been proposed, based on echocardiographic and haemodynamic data. after TAVR, were available from 247 patients (67.5%). to 94.8%)).

Aortic valve 52

Aortic valve Aortic Stenosis TAVR 52

American College of Cardiology

NOVEMBER 13, 2024

What are clinical outcomes among patients with severe aortic stenosis (AS) and coronary artery disease (CAD) undergoing surgical aortic valve replacement (SAVR) plus revascularization versus transcatheter aortic valve replacement (TAVR) plus percutaneous coronary intervention (PCI)?

Aortic valve 60

Aortic valve Coronary Artery Disease TAVR Aortic 60

Medical Xpress - Cardiology

OCTOBER 29, 2024

The first powered randomized trial examining early intervention with transcatheter aortic valve replacement (TAVR) in patients with asymptomatic, severe aortic stenosis (AS) found this strategy to be both a safe and effective alternative to clinical surveillance (CS).

Aortic valve 40

Aortic valve Aortic Stenosis TAVR 40

American College of Cardiology

OCTOBER 28, 2024

The goal of the TAVR UNLOAD trial was to evaluate transcatheter aortic valve replacement (TAVR) compared with clinical surveillance among patients with chronic systolic heart failure and moderate aortic stenosis (stage B aortic stenosis).

Aortic valve 50

Aortic valve Heart Failure Aortic TAVR 50

CardiacWire

JULY 28, 2024

These two acquisitions could impact Edwards’ structural heart and heart failure portfolios in unique and meaningful ways… JenaValve’s Trilogy TAVR system doesn’t yet have FDA approval, but is CE Marked for both aortic regurgitation and aortic stenosis, which is notable given that all other TAVR systems only address aortic stenosis.

Heart Failure 59

Heart Failure Aortic TAVR Critical Care 59